Scientific Terms
In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health
A federal judge denied four motions by Guardant but granted four others by the company.
Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay
The diagnostics and research services firm will help Mainz recruit research partners for a study assessing new biomarker additions to its CRC early detection test.
IHealth Point-of-Care SARS-CoV-2 Antigen Test Receives FDA EUA
The test qualitatively detects SARS-CoV-2 nucleocapsid antigens from anterior nasal swab samples and can be used by symptomatic or asymptomatic people.
Freenome Nets $290M Investment From Roche
The company said the latest influx brings its total funding to more than $1 billion and will help the firm expand its cancer detection platform to multiple tumor types.
NeoGenomics Blood-Based Minimal Residual Disease Test Receives CE Mark
NeoGenomics subsidiary Inivata has also submitted the RaDaR test to the MolDx program in the US for reimbursement.Â
Jan 10, 2022
Avacta Pauses Sales of Antigen Test
Jan 5, 2022
Nucleix Raises Additional $22M
Dec 30, 2021
Top 10 Articles on 360Dx in 2021
Dec 17, 2021